Schwarz Pharma Pays $22 Million to Settle False Claims Allegations Concerning Reimbursement for Unapproved Drugs #pharmaceutical #manufacturing #magazine

Posted On Apr 27 2017 by

#schwarz pharma # Justice News Schwarz Pharma Pays $22 Million to Settle False Claims Allegations Concerning Reimbursement for Unapproved Drugs WASHINGTON – Schwarz Pharma Inc. will pay $22 million to resolve False Claims Act allegations that the company failed to advise the Centers for Medicare and Medicaid Services (CMS) that two unapproved products did not qualify for coverage under federal health care programs, the Justice Department announced today. Schwarz, now a subsidiary of Belgium-based UCB S.A. is alleged to have submitted false quarterly reports to the government related to a pair of drugs, Deponit and Hyoscyamine Sulfate Extended Release (Hyoscyamine …


Sun Pharma inks pact to buy DUSA for $230 million – The Hindu #generic #drug #industry

Posted On Apr 27 2017 by

#dusa pharma # Sun Pharma inks pact to buy DUSA for $230 million Sun Pharmaceutical Industries, on Thursday, said it had inked a pact to acquire U.S.-based DUSA Pharmaceuticals for around $230 million (about Rs.1,250 crore). Sun Pharma and DUSA Pharmaceuticals have entered into a definitive agreement under which Sun Pharma will acquire DUSA, a dermatology company focused on developing and marketing its Levulan photo-dynamic therapy platform, Sun Pharma said in a statement. Under the terms of the agreement, a 100 per cent subsidiary of Sun Pharma will commence a tender offer for all of the outstanding common stock of …


URL Pharma – s $800 million deal is all about gout #lilly #pharma

Posted On Apr 19 2017 by

#url pharma # URL Pharma s $800 million deal is all about gout Mike Armstrong Some think this is the classic Philadelphia story: Club boxer gets his shot at the heavyweight title and shocks the world. To me, the classic Philadelphia story is: Businessman starts a company. Son takes over and sends it to new heights. No, I m not referring to Comcast Corp. founded in 1963 by Ralph J. Roberts and now led by his son, Brian L. Roberts, who oversaw the transactions that turned it into a media giant. Today, I m talking about a different Roberts family, …


Schwarz Pharma Pays $22 Million to Settle False Claims Allegations Concerning Reimbursement for Unapproved Drugs #trends #in #pharmaceutical #industry

Posted On Apr 19 2017 by

#schwarz pharma # Justice News Schwarz Pharma Pays $22 Million to Settle False Claims Allegations Concerning Reimbursement for Unapproved Drugs WASHINGTON – Schwarz Pharma Inc. will pay $22 million to resolve False Claims Act allegations that the company failed to advise the Centers for Medicare and Medicaid Services (CMS) that two unapproved products did not qualify for coverage under federal health care programs, the Justice Department announced today. Schwarz, now a subsidiary of Belgium-based UCB S.A. is alleged to have submitted false quarterly reports to the government related to a pair of drugs, Deponit and Hyoscyamine Sulfate Extended Release (Hyoscyamine …


Sun Pharma inks pact to buy DUSA for $230 million – The Hindu #fulcrum #pharma

Posted On Apr 18 2017 by

#dusa pharma # Sun Pharma inks pact to buy DUSA for $230 million Sun Pharmaceutical Industries, on Thursday, said it had inked a pact to acquire U.S.-based DUSA Pharmaceuticals for around $230 million (about Rs.1,250 crore). Sun Pharma and DUSA Pharmaceuticals have entered into a definitive agreement under which Sun Pharma will acquire DUSA, a dermatology company focused on developing and marketing its Levulan photo-dynamic therapy platform, Sun Pharma said in a statement. Under the terms of the agreement, a 100 per cent subsidiary of Sun Pharma will commence a tender offer for all of the outstanding common stock of …


Sun Pharma inks pact to buy DUSA for $230 million – The Hindu #pharma #logo

Posted On Apr 9 2017 by

#dusa pharma # Sun Pharma inks pact to buy DUSA for $230 million Sun Pharmaceutical Industries, on Thursday, said it had inked a pact to acquire U.S.-based DUSA Pharmaceuticals for around $230 million (about Rs.1,250 crore). Sun Pharma and DUSA Pharmaceuticals have entered into a definitive agreement under which Sun Pharma will acquire DUSA, a dermatology company focused on developing and marketing its Levulan photo-dynamic therapy platform, Sun Pharma said in a statement. Under the terms of the agreement, a 100 per cent subsidiary of Sun Pharma will commence a tender offer for all of the outstanding common stock of …


URL Pharma – s $800 million deal is all about gout #chugai #pharma

Posted On Mar 31 2017 by

#url pharma # URL Pharma s $800 million deal is all about gout Mike Armstrong Some think this is the classic Philadelphia story: Club boxer gets his shot at the heavyweight title and shocks the world. To me, the classic Philadelphia story is: Businessman starts a company. Son takes over and sends it to new heights. No, I m not referring to Comcast Corp. founded in 1963 by Ralph J. Roberts and now led by his son, Brian L. Roberts, who oversaw the transactions that turned it into a media giant. Today, I m talking about a different Roberts family, …


Dallas Pharmaceutical Startup Raises $1 Million In Investments – D Healthcare Daily #large #pharmaceutical #companies

Posted On Mar 31 2017 by

#pharmaceutical companies in dallas tx # D Healthcare Daily Dallas Pharmaceutical Startup Raises $1 Million In Investments A Dallas-based graduate of the Health Wildcatters startup incubator announced Thursday that his pharmaceutical company has raised nearly $1 million in investments just three months after the program ended. Lantern Pharma CEO Dr. Arun Asaithambi said the majority of the funds came from the angel investment firm Green Park Golf Ventures, which is also located in Dallas and has a longstanding relationship with Health Wildcatters. The company previously funneled $400,000 to Cariloop, a senior care technology company whose CEO graduated from the first …


URL Pharma – s $800 million deal is all about gout #top #100 #pharma #companies

Posted On Mar 18 2017 by

#url pharma # URL Pharma s $800 million deal is all about gout Mike Armstrong Some think this is the classic Philadelphia story: Club boxer gets his shot at the heavyweight title and shocks the world. To me, the classic Philadelphia story is: Businessman starts a company. Son takes over and sends it to new heights. No, I m not referring to Comcast Corp. founded in 1963 by Ralph J. Roberts and now led by his son, Brian L. Roberts, who oversaw the transactions that turned it into a media giant. Today, I m talking about a different Roberts family, …


In Guilty Plea, OxyContin Maker to Pay $600 Million #martindale #pharma

Posted On Mar 14 2017 by

#purdue pharmaceutical # The New York Times In Guilty Plea, OxyContin Maker to Pay $600 Million From left, Howard R. Udell, the top lawyer for Purdue Pharma; Dr. Paul D. Goldenheim, the company s former medical director; and Michael Friedman, Purdue s president. Photographs by Don Petersen for The New York Times May 10, 2007 ABINGDON, Va. May 10 — The company that makes the narcotic painkiller OxyContin and three current and former executives pleaded guilty today in federal court here to criminal charges that they misled regulators, doctors and patients about the drug’s risk of addiction and its potential …